Ischaemic heart disease in patients on chronic hemodialysis

被引:0
|
作者
Baldovinos, G [1 ]
Petraglia, A [1 ]
Borges, PL [1 ]
Alvarez, A [1 ]
Mizraji, R [1 ]
Sanz, A [1 ]
Ferreiro, A [1 ]
Moreno, M [1 ]
Nin, M [1 ]
González, F [1 ]
机构
[1] Hosp Clin Montevideo, Ctr Nefrol, Montevideo, Uruguay
来源
NEFROLOGIA | 2002年 / 22卷 / 01期
关键词
myocardial ischemia; kidney failure; chronic; hemodialysis; coronary artery bypass; CABG; angioplasty; transluminal; percutaneous coronary; PTCA;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a retrospective study of patients on chronic hemodialysis in whom a diagnosis of ischemic heart disease had been established. We compared the findings on coronary cineangiography and the treatment (medical only, surgical revascularisation [CABC] and percutaneous transluminal coronary angioplasty [PTCA]) with the early and late evolution. From a population of 2,287 patients on chronic hemodialysis treatment during the 5 year period 1994-1999, 83 patients who underwent coronary cineangiography after starting dialysis were selected. Their mean age was 63 +/- 9,4 (39-80) and the mean time on hemodialysis was 6 years (6 months-19 years). Results: 65 patients (78%) had severe coronary lesions, 40% of whom had three vessel disease. 14 patients had medical treatment only (group 7), 23 had CABC (group 2) and 28 PTCA (group 3). Mortality within 30 days of intervention was 13% in group 2 and 21.4% in group 3. Global survival at two years was 82% in group 2 and 69% in group 3. Survival without angina at 6 and 24 months were 69% and 46% in group 2 and 55% and 22% in group 3 respectively. Survival without acute myocardial infarction at 6 and 24 months was 95% and 95% in group 2 and 89% and 64% in group 3. Data analysis using Cox proportional risk model showed that PTCA posed a higher risk of angina and death than CABC. Conclusion: Surgery yielded better early and later results than angioplasty even in those patients with severe coronary artery disease.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [41] Pulse pressure and ischaemic heart disease in diabetic patients
    di Giovanni, G
    Benenato, C
    Guida, L
    Ferrara, LA
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S36 - S36
  • [42] Impaired glucose metabolism in patients with ischaemic heart disease
    Leschke, A
    Schwenk, B
    Bollinger, C
    Faehling, M
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 : 98 - 102
  • [43] Metabolic management of diabetic patients with ischaemic heart disease
    Caminiti, Giuseppe
    Marazzi, Giuseppe
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2007, 3 (3A) : S30 - S37
  • [44] Inequalities in access to care for patients with ischaemic heart disease
    Hippisley-Cox, J
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (503): : 411 - 412
  • [45] Rheological properties of blood in patients with ischaemic heart disease
    Palanduz, S
    Tamer, S
    Vatansever, S
    Karan, MA
    Çefle, K
    Öztürk, S
    Güler, K
    Kudat, H
    Kayserilioglu, A
    [J]. MEDICAL SCIENCE RESEARCH, 1999, 27 (05): : 327 - 329
  • [46] Frequency of metabolic syndrome in patients with ischaemic heart disease
    Ashraf, Tarty
    Memon, Muhammad Anis
    Talpur, Muhammad Saeed
    Panhwar, Ziauddin
    Rasool, Syed Ishtiaq
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2011, 61 (08) : 729 - 732
  • [47] A NEW PLATELET DEFECT IN PATIENTS WITH ISCHAEMIC HEART DISEASE
    BRAY, C
    MCDONALD, L
    [J]. BRITISH HEART JOURNAL, 1966, 28 (03): : 429 - &
  • [48] Screening for carotid stenosis in patients with ischaemic heart disease
    Iwata, K
    Iida, K
    Kato, T
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 1998, 5 (01) : 58 - 62
  • [49] Metabolic therapy for the diabetic patients with ischaemic heart disease
    Rosano, GMC
    Vitale, C
    Volterrani, M
    Fini, M
    [J]. CORONARY ARTERY DISEASE, 2005, 16 : S17 - S21
  • [50] Diagnosis and treatment of depression in patients with ischaemic heart disease
    Laederach-Hofmann, K
    Fisch, HU
    [J]. THERAPEUTISCHE UMSCHAU, 2003, 60 (11) : 703 - 707